Dimerization of Protein Tyrosine Phosphatase σ Governs both Ligand Binding and Isoform Specificity

Abstract

Signaling through receptor protein tyrosine phosphatases (RPTPs) can influence diverse processes, including axon development, lymphocyte activation, and cell motility. The molecular regulation of these enzymes, however, is still poorly understood. In particular, it is not known if, or how, the dimerization state of RPTPs is related to the binding of extracellular ligands. Protein tyrosine phosphatase σ (PTPσ) is an RPTP with major isoforms that differ in their complements of fibronectin type III domains and in their ligand-binding specificities. In this study, we show that PTPσ forms homodimers in the cell, interacting at least in part through the transmembrane region. Using this knowledge, we provide the first evidence that PTPσ ectodomains must be presented as dimers in order to bind heterophilic ligands. We also provide evidence of how alternative use of fibronectin type III domain complements in two major isoforms of PTPσ can alter the ligand binding specificities of PTPσ ectodomains. The data suggest that the alternative domains function largely to change the rotational conformations of the amino-terminal ligand binding sites of the ectodomain dimers, thus imparting novel ligand binding properties. These findings have important implications for our understanding of how heterophilic ligands interact with, and potentially regulate, RPTPs.

The research was funded by the Wellcome Trust (D.A. and M.H.; 071418), the Child Health Research Appeal Trust (S.L.), the BBSRC (United Kingdom) (C.F. and J.N.; 31/C17480), and EC Network HPRN-CT-2000-00085.

We thank Radu Aricescu for critical reading of the manuscript and Plasso Technology Ltd. for their generous gift of heparin binding plates.